Wang Z-H, Wang J-H, Wang K-Q, Zhou Y, Wang J
Department of Urology, West China Hospital, Sichuan University, Chengdu, China.
Eur Rev Med Pharmacol Sci. 2020 Aug;24(16):8250. doi: 10.26355/eurrev_202008_22591.
The article "LncRNA FEZF1-AS1 promoted chemoresistance, autophagy and epithelial-mesenchymal transition (EMT) through regulation of miR-25-3p/ITGB8 axis in prostate cancer, by Z.-H. Wang, J.-H. Wang, K.-Q. Wang, Y. Zhou, J. Wang, published in Eur Rev Med Pharmacol Sci 2020; 24(5): 2281-2293-DOI: 10.26355/eurrev_202003_20494-PMID: 32196579" has been withdrawn from the authors. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/20494.
由王Z.-H.、王J.-H.、王K.-Q.、周Y.、王J.发表于《欧洲医学与药理学评论》2020年;24(5): 2281 - 2293 - DOI: 10.26355/eurrev_202003_20494 - PMID: 32196579的文章《长链非编码RNA FEZF1 - AS1通过调控miR - 25 - 3p/ITGB8轴促进前列腺癌的化疗耐药、自噬和上皮-间质转化》已被作者撤回。出版商对由此可能造成的任何不便表示歉意。https://www.europeanreview.org/article/20494 。